Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
FASEB J ; 20(8): 1212-4, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16627626

RESUMO

Nicotine reduces beta-amyloidosis and has a beneficial effect against Alzheimer's disease (AD), but the underlying mechanism is not clear. The abnormal interactions of beta-amyloid (Abeta) with metal ions such as copper and zinc are implicated in the process of Abeta deposition in AD brains. In the present study, we investigated the effect of nicotine on metal homeostasis in the hippocampus and cortex of APP(V717I) (London mutant form of APP) transgenic mice. A significant reduction in the metal contents of copper and zinc in senile plaques and neuropil is observed after nicotine treatment. The densities of copper and zinc distributions in a subfield of the hippocampus CA1 region are also reduced after nicotine treatment. We further studied the mechanism of nicotine-mediated effect on metal homeostasis by using SH-SY5Y cells overexpressing the Swedish mutant form of human APP (APPsw). Nicotine treatment decreases the intracellular copper concentration and attenuates Abeta-mediated neurotoxicity facilitated by the addition of copper, and these effects are independent of the activation of nicotinic acetylcholine-receptor. These data suggest that the effect of nicotine on reducing beta-amyloidosis is partly mediated by regulating metal homeostasis.


Assuntos
Precursor de Proteína beta-Amiloide/metabolismo , Amiloidose/metabolismo , Cobre/metabolismo , Fármacos Neuroprotetores/farmacologia , Nicotina/farmacologia , Peptídeos beta-Amiloides/metabolismo , Precursor de Proteína beta-Amiloide/genética , Amiloidose/patologia , Animais , Sobrevivência Celular/efeitos dos fármacos , Cobre/antagonistas & inibidores , Cobre/farmacologia , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Hipocampo/patologia , Homeostase , Humanos , Metais/metabolismo , Camundongos , Camundongos Transgênicos , Chaperonas Moleculares/metabolismo , Fragmentos de Peptídeos/metabolismo , Placa Amiloide/efeitos dos fármacos , Placa Amiloide/patologia , Espécies Reativas de Oxigênio/metabolismo , Receptores Nicotínicos/metabolismo , Superóxido Dismutase/metabolismo , Superóxido Dismutase-1
2.
Zhonghua Yu Fang Yi Xue Za Zhi ; 39(1): 30-2, 2005 Jan.
Artigo em Chinês | MEDLINE | ID: mdl-15794888

RESUMO

OBJECTIVE: To investigate the changing of T4 5'-and 5-deiodinase within rat brain under various iodin-nutritional states. METHODS: Animal model of iodine-deficiency rat was performed and the rats were divided into 4 groups by the intake of iodine-nutrition, and then killed at an age of 20 days. The thyroid hormones level in serum was measured by ELISA and the activity of T(4) 5'-and 5-deiodinase within brain was analyzed. RESULTS: In less-iodine (LI) group,TT4 and FT4 were accounting for 3.5% of the neutral-iodine (NI) group's, and FT3 was 174.0% of NI group's (P < 0.05). In NI group,TT4 and FT4 were 114.5% and 127.7% of NI group's (P < 0.05). In high-iodine (HI) group, TT4 and FT4 were 61.86% and 62.0% of NI group's, and FT3 was 184.9% of NI group's (P < 0.05). In LI group, the activity of T4 5'-deiodinase tissue of per gram (1.95 +/- 0.32) ngT3.microgT4(-1).h was significantly higher than that of NI group (P < 0.05), and the activity of 5-deiodinase (1.38 +/- 0.21) ngrT3.microg T4(-1).h(-1) is significantly less than that of NI group (1.59 +/- 0.23) (P < 0.05). In HI group the activity of T4 5'-and 5-deiodinase tissue of per gram (1.12 +/- 0.19 and 1.73 +/- 0.36) ngrT3.microgT4(-1).h(-1)was significantly less than that of NI group (P < 0.05). CONCLUSION: The activity of T4 5'-deiodinase in iodine deficiency heightens and that in iodine excess is debased, the activity of T4 5-deiodinase in iodine deficiency and in iodine excess is debased.


Assuntos
Encéfalo/enzimologia , Iodeto Peroxidase/metabolismo , Iodo/administração & dosagem , Iodo/deficiência , Animais , Feminino , Masculino , Ratos , Ratos Wistar , Tiroxina/sangue , Tri-Iodotironina/sangue
3.
Free Radic Biol Med ; 37(7): 1037-50, 2004 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-15336320

RESUMO

Oxidative stress is considered to be a mechanism involved in lead neurotoxicity. Apoptosis is also thought to relate to lead neurotoxicity. The present study, focused on the hippocampus, was designed to investigate the two possible mechanisms involved in lead neurotoxicity and the potential protective effects of 2,3-dimercaptosuccinic acid (DMSA) and oligomeric procyanidins (OPC). It was proved that reactive oxygen species and oxidative damage were implicated in the induction of apoptosis induced by lead in the hippocampus. Administration of DMSA attenuated the oxidative stress and apoptosis in addition to having strong chelating and lead-removing capacity. OPC alone had antioxidant protective effects in the hippocampus but no removing capacity for lead in vivo despite showing higher affinity and stronger chelating ability for Pb(2+) than DMSA in vitro. It is suggested that OPC chelates Pb(2+) but does not discharge it from the body and even accumulates Pb(2+) in some organs. At the same time, a reasonable deduction can also be made that the complex of OPC-Pb(2+) prevents or at least weakens the neurotoxicity of Pb(2+). Whether this complex displays toxicity over a long time span should be studied further.


Assuntos
Antocianinas/química , Antocianinas/farmacologia , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , Chumbo/toxicidade , Neurônios/efeitos dos fármacos , Succímero/farmacologia , Animais , Apoptose/efeitos dos fármacos , Quelantes/farmacologia , Sequestradores de Radicais Livres/farmacologia , Radicais Livres/metabolismo , Glutationa/química , Glutationa/metabolismo , Glutationa Redutase/metabolismo , Hipocampo/metabolismo , Intoxicação por Chumbo/metabolismo , Intoxicação por Chumbo/patologia , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Neurônios/citologia , Neurônios/metabolismo , Oxirredução/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Ratos , Ratos Sprague-Dawley , Fatores de Tempo , Proteína X Associada a bcl-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA